NovaSight

Lod, Israel · Founded 2016 · Privately Held (backing)

Developer of a pediatric ophthalmology medical device intended to integrate data analytics into a range of medical devices. NovaSight is based in Lod, Israel and was founded in 2016. Its last reported valuation was $47.3 million in Aug 2025. It has raised $38.3 million.

Last reported valuation
$47.3M
Oct 2026
Priced at
—
Total raised
$38.3M
Last round
—

Who backs NovaSight?

9 investors
InvestorType
Innovation AuthorityOther
Yunjin (Suzhou) Capital ManagementOther
Arbelon HoldingsFamily office
Club 100 plus—
Dagesh—
Gold Track—
Rimonci Capital—
Sanara Capital—
Santen—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NovaSight investors

9 investors are on record for NovaSight, including Innovation Authority, Yunjin (Suzhou) Capital Management, Arbelon Holdings and Club 100 plus.

Free account
More of NovaSight with a free account
  • ·Watch NovaSight: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like NovaSight. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View